CJ has entered into a capital contribution agreement through its subsidiary CJ Bio America, Inc. to establish a joint venture with U.S. ADM.

CJ has decided to establish a joint venture for a global feed amino acid business with U.S. Archer-Daniels-Midland Company (ADM) through its subsidiary CJ Bio America, Inc. The joint venture will have CJ Bio America, Inc. holding 63% and ADM holding 37% of the equity, with CJ America, Inc.'s feed amino acid business and stakes in Mexican and Brazilian related companies to be contributed in kind. The company said this will strengthen competitiveness in the global feed amino acid business and pursue stable procurement of raw materials.

1. 01

   CJ Bio America, Inc. and U.S. Archer-Daniels-Midland Company (ADM) will establish a joint venture to pursue a global feed amino acid business.

2. 02

   The joint venture's equity will be structured with CJ Bio America, Inc. holding 63% and ADM holding 37%.

3. 03

   CJ America, Inc.'s entire feed amino acid business and related company stakes will be contributed in kind to the joint venture through CJ Bio America, Inc.

4. 04

   If losses arise from breach of contract or failure to perform obligations by CJ Bio America, Inc., CJ Bio America, Inc. will indemnify; if not indemnified within 30 days, CJ will indemnify.

An AI model translated the Korean summary of this filing into English; every number is carried over from the Korean original. Reference information, not investment advice.

Key figures

CJ Bio America, Inc.'s joint venture equity stake

63%

ADM's joint venture equity stake

37%

CJ CheilJedang Mexico, S.A. de C.V. stake

99.99%

CJ do Brasil Ltda. stake

100%

Contract execution date

October 2, 2026

Filing facts

Filing type

Material Management Information

Report name

Material Management Information for Investment Decisions (Subsidiary)

Filed

Oct 2, 2026

Receipt number

20261002800987